Deborah Vliet
Nurse Practitioner · Stevensville, MINPI 1881666501
Payments from drug & device makers
Across 332 payments — averaging $15.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Xeris Pharmaceuticals, Inc.$666
- AstraZeneca$332
- Dexcom, Inc.$324
- Boehringer Ingelheim$301
- Bayer$224
- plus $2K from 25 others
What the payments were for
- Food & beverage$4,973100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 103 | $1,067 |
| Xeris Pharmaceuticals, Inc. | 39 | $666 |
| AstraZeneca(2 entities) | 12 | $332 |
| Dexcom, Inc. | 20 | $324 |
| Boehringer Ingelheim | 20 | $301 |
| Bayer | 15 | $224 |
| Lilly USA, LLC | 15 | $220 |
| Amarin Pharma, Inc. | 11 | $201 |
| Sanofi-aventis U.S. LLC | 11 | $178 |
| Novartis | 11 | $172 |
| Corcept Therapeutics | 10 | $154 |
| Amgen(2 entities) | 7 | $114 |
| Recordati_rare_diseases_inc. | 4 | $112 |
| Tandem Diabetes Care, Inc. | 6 | $111 |
| Medtronic | 7 | $99 |
| Abbott | 5 | $97 |
| Insulet Corporation | 6 | $84 |
| Pfizer | 4 | $80 |
| Actelion Pharmaceuticals US, Inc. | 3 | $61 |
| Antares Pharma, Inc. | 3 | $52 |
| Radius Health, Inc. | 3 | $51 |
| AbbVie | 3 | $49 |
| Amneal Pharmaceuticals LLC | 2 | $41 |
| GSK | 2 | $38 |
| EUSA Pharma (US) LLC | 2 | $33 |
| Merck | 2 | $31 |
| Amryt Pharma Holdings Ltd | 2 | $30 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
| Astellas Pharma US Inc | 1 | $16 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| IBSA Pharma Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$116
How this compares
$4,985 in reported general payments places this provider in the 95th percentile of 3,351 nurse practitioner providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 66 | $90,804 |
| OzempicSemaglutide | 54 | $66,093 |
| JardianceEmpagliflozin | 43 | $54,365 |
| MounjaroTirzepatide | 26 | $40,264 |
| FarxigaDapagliflozin Propanediol | 34 | $35,400 |
| Novolog FlexpenInsulin Aspart | 48 | $18,729 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $18,685 |
| InvokanaCanagliflozin | 13 | $16,292 |
| Tresiba Flextouch U-100Insulin Degludec | 23 | $14,854 |
| Tresiba Flextouch U-200Insulin Degludec | 13 | $14,762 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 77 | $12,481 |
| JanuviaSitagliptin Phosphate | 14 | $9,995 |
| Humalog Kwikpen U-100Insulin Lispro | 17 | $6,265 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 27 | $3,910 |
| Ultra-Fine Nano Pen NeedlePen Needle, Diabetic | 13 | $1,395 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $220 | $131,06992 claims |
| Novo NordiskOzempic | $1,067 | $66,09354 claims |
| Boehringer IngelheimJardiance | $301 | $54,36543 claims |
| AstraZenecaFarxiga | $332 | $35,40034 claims |
| MerckJanuvia | $31 | $9,99514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,351 nurse practitioner providers in Michigan.
Other nurse practitioner in Stevensville
- Davida KrugerDetroit$1.8M
- Kari HillSpring Lake$426K
- Kyle FarrPlymouth$243K
- Linda SpencerTroy$217K
- Ellen DillardDetroit$168K
- Golbon AghamohammadiDetroit$157K
- Abubakir BabanDearborn$143K
- Elizabeth KirshnerAnn Arbor$119K
- Lisa Astalos ChismWoodhaven$103K
- Martha GoetzPetoskey$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.